(Total Views: 644)
Posted On: 03/01/2024 4:52:51 PM
Post# of 151766
Finally, the word is accurately breaking through. Old news for all of us, of course.
“ It is a competitive rather than allosteric inhibitor of the CCR5 receptor. This mechanism of action of binding competitively to the CCR5 receptor differentiates leronlimab from all other CCR5 antagonists.”
“ It is a competitive rather than allosteric inhibitor of the CCR5 receptor. This mechanism of action of binding competitively to the CCR5 receptor differentiates leronlimab from all other CCR5 antagonists.”
(5)
(0)Scroll down for more posts ▼
